Decarboxylase

Catalog No.	Product Name	Solubility(25°C)
Catalog No.	Product Name	Water	DMSO	Alcohol
S1891	Carbidopa	<1 mg/mL	4 mg/mL	<1 mg/mL
S2453	Benserazide HCl	58 mg/mL	58 mg/mL	1 mg/mL
S1642	Methyldopa	<1 mg/mL	2 mg/mL	<1 mg/mL
S4582	Eflornithine hydrochloride hydrate	47 mg/mL	<1 mg/mL	<1 mg/mL
S5448	S(-)-Carbidopa	<1 mg/mL	0.01 mg/mL	<1 mg/mL
S5444	4-Bromo-3-hydroxybenzoic acid	-1 mg/mL	43 mg/mL	-1 mg/mL

Catalog No.	Information	Product Use Citations	Product Validations
S1891	Carbidopa Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor with an IC50 of 29 ± 2 μM.
S2453	Benserazide HCl Benserazide HCl is a peripherally-acting aromatic L-amino acid decarboxylase (AAAD) or DOPA decarboxylase inhibitor.
S1642	Methyldopa Methyldopa (Aldomet) is a DOPA decarboxylase competitive inhibitor with an ED50 of 21.8 mg/kg.
S4582	Eflornithine hydrochloride hydrate Eflornithine(Difluoromethylornithine) inhibits polyamine biosynthesis by the selective, irreversible inhibition of ornithine decarboxylase (ODC). A chemoprotective agent that blocks angiogenesis. Its biological half-life is 8 hours.
S5448^New	S(-)-Carbidopa S(-)-Carbidopa is a peripheral decarboxylase inhibitor, used in combination with levodopa for treatment of Parkinsonism.
S5444^New	4-Bromo-3-hydroxybenzoic acid 4-bromo-3-hydroxybenzoic acid is a potent inhibitor of the enzyme histidine decarboxylase with resultant inhibition of histamine formation in mammals.